2024 · Abstract/Manuscript · University of Alabama at Birmingham
President of Headwater Science
M. Alan Brookhart, PhD
Alan is a biostatistician and an epidemiologist who has spent the last 15 years developing and applying epidemiological and statistical methods for studies using real-world healthcare data. He has more than 200 publications in leading journals in medicine, biostatistics, and epidemiology. In 2021 Target RWE acquired his company NoviSci, Inc., a company that built and applied analytic software and visualization tools for RWE generation.
Alan is also a Professor in the Department of Population Health Sciences at Duke University, an Adjunct Professor at UNC Chapel Hill, and an Honorary Professor of Clinical Epidemiology at the University of Aarhus, Denmark. Previously Alan was on faculty at Harvard Medical School and was also a co-founder and chair of the scientific advisory board of RxAnte, Inc., a provider of widely used predictive analytics for decision support. Alan is a member of many scientific advisory groups, review panels, and editorial boards.

Publications
8
Total Publications
2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill
Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation
Read more →2021 · Abstract/Manuscript · Amgen Inc.
Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice
Read more →2021 · Abstract/Manuscript · University of North Carolina at Chapel Hill
Medicaid Coverage Disruptions Among Children Enrolled in North Carolina Medicaid From 2016 to 2018
Read more →2020 · Abstract/Manuscript · Amgen Inc.
Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States
Read more →2020 · Abstract/Manuscript · University of Alabama at Birmingham
Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines
Read more →2018 · Abstract/Manuscript · University of North Carolina at Chapel Hill
Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States
Read more →2018 · Abstract/Manuscript · University of North Carolina at Chapel Hill